This website uses cookies to enhance the user experience.
N

NORDA ASA984 648 820

Research
Public limited company
Grundingen 3 0250 OSLO, Norge

NORDA ASA

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
23 years
since Jul 1, 2002
Type
Public limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
5,148,808
1 share class
Total number of shareholders
479
44 companies, 435 persons

Financials

Total operating income 2024
371,859,312
NOK
Annual total result 2024
125,948,213
NOK
Total equity 2024
302,063,163
NOK
Last update: May 27, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman
6.96 %
directly 5.95 %
indirectly 1.01 %
Board Member-
Board Member-

Others

NameRoleShares
C
CROWE PARTNER REVISJON AS
Auditor-
E
ECIT VEIBY AKONTO AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
54.99 %
directly 54.18 %
indirectly 0.81 %
-
9.13 %
indirectly
-
9.13 %
indirectly
Chairman
6.96 %
directly 5.95 %
indirectly 1.01 %
-
4.06 %
directly 3.99 %
indirectly 0.07 %
Last update: May 7, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
NO0010285190
2,789,716
54.18 %
T
TARA AS
NO0010285190
1,397,783
27.15 %
NO0010285190
306,263
5.95 %
NO0010285190
205,298
3.99 %
C
CAABY AS
NO0010285190
52,033
1.01 %
NO0010285190
50,000
0.97 %
L
LUCY AS
NO0010285190
40,579
0.79 %
R
RWD AS
NO0010285190
35,000
0.68 %
NO0010285190
25,000
0.49 %
N
NORDA ASA
NO0010285190
17,018
0.33 %
NO0010285190
9,838
0.19 %
NO0010285190
7,500
0.15 %
NO0010285190
6,358
0.12 %
NO0010285190
5,000
0.1 %
M
MASITO AS
NO0010285190
4,946
0.1 %
F
FINYIELD AS
NO0010285190
4,802
0.09 %
NO0010285190
4,136
0.08 %
NO0010285190
4,002
0.08 %
NO0010285190
3,667
0.07 %
NO0010285190
3,199
0.06 %
NO0010285190
3,033
0.06 %
NO0010285190
3,029
0.06 %
NO0010285190
3,000
0.06 %
NO0010285190
2,600
0.05 %
NO0010285190
2,546
0.05 %
NO0010285190
2,526
0.05 %
NO0010285190
2,523
0.05 %
NO0010285190
2,500
0.05 %
N
NORDNET LIVSFORSIKRING AS
NO0010285190
2,470
0.05 %
NO0010285190
2,339
0.05 %
O
ODIN HENRIKSSEN & SØNN AS
NO0010285190
2,150
0.04 %
NO0010285190
2,138
0.04 %
NO0010285190
2,070
0.04 %
J
J E GREVE AS
NO0010285190
2,058
0.04 %
NO0010285190
2,000
0.04 %
NO0010285190
1,700
0.03 %
NO0010285190
1,700
0.03 %
NO0010285190
1,646
0.03 %
NO0010285190
1,571
0.03 %
NO0010285190
1,500
0.03 %
NO0010285190
1,500
0.03 %
NO0010285190
1,500
0.03 %
NO0010285190
1,458
0.03 %
LE
NO0010285190
1,393
0.03 %
NO0010285190
1,393
0.03 %
S
ST JAKOBSPLASS 9 AS
NO0010285190
1,358
0.03 %
NO0010285190
1,200
0.02 %
NO0010285190
1,199
0.02 %
L
LINDEFJELL HOLDING AS
NO0010285190
1,055
0.02 %
NO0010285190
1,050
0.02 %
NO0010285190
1,040
0.02 %
J
JORA MASKIN AS
NO0010285190
1,032
0.02 %
V
VIATICUS ANS
NO0010285190
1,009
0.02 %
NO0010285190
1,002
0.02 %
NO0010285190
1,000
0.02 %
NO0010285190
1,000
0.02 %
NO0010285190
1,000
0.02 %
NO0010285190
1,000
0.02 %
NO0010285190
1,000
0.02 %
I
INTERTRADE SHIPPING AS
NO0010285190
981
0.02 %
NO0010285190
905
0.02 %
NO0010285190
800
0.02 %
NO0010285190
750
< 0.01 %
NO0010285190
750
< 0.01 %
NO0010285190
750
< 0.01 %
I
INSR ASA
NO0010285190
734
< 0.01 %
NO0010285190
730
< 0.01 %
NO0010285190
700
< 0.01 %
NO0010285190
700
< 0.01 %
NO0010285190
600
< 0.01 %
NO0010285190
598
< 0.01 %
NO0010285190
580
< 0.01 %
NO0010285190
540
< 0.01 %
NO0010285190
537
< 0.01 %
NO0010285190
533
< 0.01 %
NO0010285190
533
< 0.01 %
NO0010285190
526
< 0.01 %
NO0010285190
501
< 0.01 %
NO0010285190
500
< 0.01 %
NO0010285190
500
< 0.01 %
NO0010285190
500
< 0.01 %
NO0010285190
455
< 0.01 %
NO0010285190
450
< 0.01 %
NO0010285190
400
< 0.01 %
NO0010285190
400
< 0.01 %
NO0010285190
370
< 0.01 %
NO0010285190
360
< 0.01 %
NO0010285190
345
< 0.01 %
NO0010285190
341
< 0.01 %
NO0010285190
333
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
300
< 0.01 %
NO0010285190
288
< 0.01 %
NO0010285190
277
< 0.01 %

Shares owned by the NORDA ASA

NameShare classTotal number of sharesShare
I
INSR ASA
NO0010593544
84,856,304
23.43 %
L
LATTICE INTERNATIONAL AS
Ordinary shares
113,889
6.36 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
12,996,755
3.98 %
M
MORROW BANK ASA
NO0010694029
5,818,047
2.53 %
L
LOKOTECH GROUP AS
NO0010921299
3,320,524
1.89 %
Z
ZELLUNA IMMUNOTHERAPY AS
NO0010820731
230,028
1.88 %
A
APIM THERAPEUTICS AS
NO0010734734
25,510
1.48 %
E
EXACT THERAPEUTICS AS
NO0010852213
860,215
1.36 %
A
AKER BIOMARINE ASA
NO0010886625
982,489
1.12 %
F
FLYCO AS
NO0010940513
500,000
1.12 %
O
ONCOINVENT ASA
NO0010779341
957,692
1.04 %
S
SMARTCRAFT ASA
NO0011008971
1,353,358
0.79 %
N
NORBIT ASA
NO0010856511
434,045
0.68 %
S
SPINCHIP DIAGNOSTICS AS
NO0010765001
4,585
0.39 %
H
HEXAGON COMPOSITES ASA
NO0003067902
700,511
0.33 %
N
NORDA ASA
NO0010285190
17,018
0.33 %
E
EIENDOMSSPAR AS
NO0003998700
76,300
0.23 %
S
SALAMANDER INVEST AS
NO0010754773
711,010
0.11 %
N
NORDIC SEMICONDUCTOR ASA
NO0003055501
200,000
0.1 %
H
HAVILA SHIPPING ASA
NO0010257728
451
< 0.01 %
M
MORELD ASA
NO0013325506
12,328
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
371,859,312
86,923,243
127,973,045
139,319,924
Annual Total Result
125,948,213
31,173,334
100,241,617
82,137,550
Total assets
929,579,274
822,054,720
691,959,995
727,968,261
Total liabilities
627,516,112
511,122,052
362,156,662
498,008,584
Total equity
302,063,163
310,932,668
329,803,333
229,959,678

P&L

Year2024202320222021
Total operating income
371,859,312
86,923,243
127,973,045
139,319,924
Total operating costs
210,310,709
32,413,832
19,533,933
52,620,989
Operating result
161,548,604
54,509,411
108,439,112
86,698,935
Financial income/costs
-35,600,390
-23,336,077
-8,197,495
-4,561,385
Profit before tax
125,948,213
31,173,334
100,241,617
82,137,550
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
125,948,213
31,173,334
100,241,617
82,137,550

Balance overview

Year2024202320222021
Total fixed assets
128,737,339
52,915,286
74,907,238
72,152,658
Total current assets
800,841,935
769,139,435
617,052,757
655,815,603
Total assets
929,579,274
822,054,720
691,959,995
727,968,261
Short term debt
627,516,112
511,122,052
362,156,662
498,008,584
Long term debt
0
0
0
0
Total liabilities
627,516,112
511,122,052
362,156,662
498,008,584
Contributed capital
23,520,420
23,521,057
23,521,440
23,524,908
Retained earnings
278,542,743
287,411,611
306,281,892
206,434,769
Total equity
302,063,163
310,932,668
329,803,333
229,959,678
Total equity and liabilities
929,579,274
822,054,720
691,959,995
727,968,261

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology